Not applicableStudy completedNCT00438906What this trial is testingCancer of the Pancreas Screening Study (CAPS 3)Who this might be right forPancreatic NeoplasmPeutz-Jeghers Syndrome Johns Hopkins University 200
Not applicableStudy completedNCT04425200What this trial is testingPrevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World SettingWho this might be right forProstatic Neoplasms AstraZeneca 205
Testing effectiveness (Phase 2)Ended earlyNCT04030559What this trial is testingNiraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsWho this might be right forATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+14 more University of California, Davis 11
Early research (Phase 1)Active Not RecruitingNCT05787587What this trial is testingPARG Inhibitor IDE161 in Participants With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+6 more IDEAYA Biosciences 216
Not applicableStudy completedNCT06490510What this trial is testingPrognostic Significance of Mutation Type and Chromosome Fragility in Fanconi AnemiaWho this might be right forFanconi Anemia Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 227
Not applicableStudy completedNCT02039388What this trial is testingLavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial CarcinomaWho this might be right forOvarian Epithelial CancerCarcinoma in SituOvarian Cancer Medical University of Vienna 701
Not applicableStudy completedNCT03889171What this trial is testingComparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics TestsWho this might be right forCancerColorectal CancerBreast Cancer+1 more University Hospital, Montpellier 200
Testing effectiveness (Phase 2)UnknownNCT01772979What this trial is testingStudy With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian CancerWho this might be right forBRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Catholic University of the Sacred Heart 100
Early research (Phase 1)Study completedNCT01339650What this trial is testingStudy of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian TubePrimary Peritoneal CancerSolid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian AbbVie (prior sponsor, Abbott) 93
Large-scale testing (Phase 3)Study completedNCT00001806What this trial is testingMethods in Education for Breast Cancer GeneticsWho this might be right forBreast CancerOvarian Cancer National Cancer Institute (NCI) 170
Testing effectiveness (Phase 2)WithdrawnNCT06392841What this trial is testingNiraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair AlterationsWho this might be right forMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Deleterious HRR Gene MutationBRCA1 Gene Mutation+7 more Qian Qin
Testing effectiveness (Phase 2)Study completedNCT03377556What this trial is testingLung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung CancerWho this might be right forATM Gene MutationATR Gene MutationBARD1 Gene Mutation+18 more SWOG Cancer Research Network 51
Not applicableActive Not RecruitingNCT04613440What this trial is testingFaCT Trial (Facilitated Cascade Testing Trial)Who this might be right forBRCA1 MutationBRCA2 Mutation Weill Medical College of Cornell University 524
Post-approval studies (Phase 4)UnknownNCT00413491What this trial is testingNational Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 MutationsWho this might be right forBreast Cancer Danish Breast Cancer Cooperative Group 300
Not applicableUnknownNCT00155896What this trial is testingEstablishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian CancerWho this might be right forOvarian Cancer National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00453388What this trial is testingFludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi AnemiaWho this might be right forAcute Myeloid Leukemia in Remissionde Novo Myelodysplastic SyndromeFanconi Anemia+1 more Fred Hutchinson Cancer Center 6
Not applicableActive Not RecruitingNCT07821229What this trial is testingCombination of Mitomycin and Carboplatin in Neoadjuvant Therapy in BRCA-associated Triple-negative Locally Advanced Breast CancerWho this might be right forBreast Cancer (Early Breast Cancer)BRCA 1 Gene MutationBRCA 2 Gene Mutation N.N. Petrov National Medical Research Center of Oncology 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04042831What this trial is testingOlaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene MutationsWho this might be right forBile Duct AdenocarcinomaFanconi Anemia Complementation Group Gene MutationMetastatic Bile Duct Carcinoma+1 more Academic and Community Cancer Research United 32
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83
Testing effectiveness (Phase 2)Looking for participantsNCT05485766What this trial is testingNovel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerWho this might be right forTriple Negative Breast NeoplasmsTriple Negative Breast CancerBreast Neoplasms+5 more Okayama University 23